Back to the main directory
Press Release
- Knight présentera à la conférence des investisseurs en santé Bloom Burton & Co. 2024 by GlobeNewsWire
- SL Green Signs Leases Totaling 104,000 Square Feet at One Madison Avenue by GlobeNewsWire
- Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement by GlobeNewsWire
- Elis : Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 03 2024 by GlobeNewsWire
- Carbon Revolution Announces Record Revenue Results for First Half 2024 by GlobeNewsWire
- Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference by GlobeNewsWire
- WisdomTree Reports Monthly Metrics for March 2024 by BusinessWire
- Mainz Biomed Reports Full Year 2023 Financial Results by GlobeNewsWire
- Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis by GlobeNewsWire
- Whitestone REIT Acquires Scottsdale Commons by GlobeNewsWire
- Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis by GlobeNewsWire
- Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing by GlobeNewsWire
- Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024 by GlobeNewsWire
- Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting by GlobeNewsWire
- Red Cat Begins Integration of Teal 2 Drones with Ocean Power Technologies Maritime Surveillance Solution for Air, Sea, and Subsea Defense and Security Missions by GlobeNewsWire
- NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease by GlobeNewsWire
- Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors by GlobeNewsWire
- iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation by GlobeNewsWire
- Freddie Mac Sells $104 Million in Non-Performing Loans by GlobeNewsWire
- Sysco to Announce Third Quarter Fiscal Year 2024 Financial Results on April 30 by GlobeNewsWire
- Silicon Motion Announces Preliminary First Quarter 2024 Revenue and Earnings Conference Call Details by GlobeNewsWire
- BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo by GlobeNewsWire
- Aemetis Allocated $10.5 Million IRA Section 48C Tax Credits by DOE and IRS for Biofuels Plant Efficiency Projects by GlobeNewsWire
- Inspired to Report Fourth Quarter and Fiscal Year 2023 Results and Hold Conference Call on April 15 by GlobeNewsWire
- Clearmind Medicine CEO Issues Letter to Shareholders by GlobeNewsWire